Cystic fibrosis papers of the year 2017
- PMID: 29627168
- DOI: 10.1016/j.prrv.2018.03.001
Cystic fibrosis papers of the year 2017
Abstract
The number of published articles on Cystic Fibrosis (CF) continues to increase year on year. The evidence base for small molecule therapies in CF has continued to expand, with evidence for lumacaftor/ivacaftor in younger patients and longer-term evidence in adults, and pivotal studies on tezacaftor/ivacaftor. There were reports on emerging CFTR mutation agnostic therapies, and new evidence for long standing therapies.
Keywords: Cystic fibrosis; Doxycycline; Ivacaftor; Lumacaftor; MRSA; Tezacaftor.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
